Literature DB >> 20735887

Executive function in patients with obstructive sleep apnea treated with continuous positive airway pressure.

Esther Yuet Ying Lau1, Gail A Eskes, Debra L Morrison, Malgorzata Rajda, Kathleen F Spurr.   

Abstract

Obstructive sleep apnea (OSA) is characterized by disrupted breathing and hypoxemia during sleep, daytime sleepiness, and changes in cognition and mood. One important question is regarding the reversibility of cognitive deficits after treatment with continuous positive airway pressure (CPAP). Here, we report the outcomes of CPAP treatment as measured by tests of attention and executive function. Thirty-seven individuals with moderate to severe OSA and compliant on CPAP treatment were studied with working memory tasks, neuropsychological testing, and overnight polysomnographic sleep study and compared to 27 healthy controls. CPAP improved the respiratory disturbance index, minimum and mean oxygen saturation (SpO2), subjective sleep quality, and daytime sleepiness ratings compared to pre-treatment values. In terms of current neurocognitive function, treated individuals with OSA performed at a comparable level to controls on basic working memory storage functions but still showed a significant reduction on tests of working memory requiring the central executive. The OSA group also performed worse on neuropsychological measures of complex attention, executive function, and psychomotor speed. While CPAP is an effective treatment for OSA in terms of ameliorating breathing disruption and oxygen desaturation during sleep, as well as daytime sleepiness, some cognitive deficits may be more resistant to treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20735887     DOI: 10.1017/S1355617710000901

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  32 in total

1.  Is brain injury in obstructive sleep apnea reversible?

Authors:  Paul M Macey
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

Review 2.  Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer.

Authors:  Nadia Gildeh; Panagis Drakatos; Sean Higgins; Ivana Rosenzweig; Brian D Kent
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

3.  CPAP or placebo-effect?

Authors:  Skai W Schwartz; Cynthia R Cimino; W McDowell Anderson
Journal:  Sleep       Date:  2012-12-01       Impact factor: 5.849

4.  Performance of facial expression classification tasks in patients with obstructive sleep apnea.

Authors:  Junfeng Guo; Yingjuan Ma; Zhenhua Liu; Fumin Wang; Xunyao Hou; Jian Chen; Yan Hong; Song Xu; Xueping Liu
Journal:  J Clin Sleep Med       Date:  2020-04-15       Impact factor: 4.062

Review 5.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

Review 6.  Obstructive sleep apnea and delirium: exploring possible mechanisms.

Authors:  Aibek E Mirrakhimov; Carey L Brewbaker; Andrew D Krystal; Madan M Kwatra
Journal:  Sleep Breath       Date:  2013-04-14       Impact factor: 2.816

7.  Delirium after cardiac surgery: have we overlooked obstructive sleep apnea?

Authors:  Aibek E Mirrakhimov; Timothy Yen; Madan M Kwatra
Journal:  Med Hypotheses       Date:  2013-04-22       Impact factor: 1.538

Review 8.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

9.  Alzheimer's disease, sleep apnea, and positive pressure therapy.

Authors:  Donald L Bliwise
Journal:  Curr Treat Options Neurol       Date:  2013-12       Impact factor: 3.598

10.  Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES).

Authors:  Clete A Kushida; Deborah A Nichols; Tyson H Holmes; Stuart F Quan; James K Walsh; Daniel J Gottlieb; Richard D Simon; Christian Guilleminault; David P White; James L Goodwin; Paula K Schweitzer; Eileen B Leary; Pamela R Hyde; Max Hirshkowitz; Sylvan Green; Linda K McEvoy; Cynthia Chan; Alan Gevins; Gary G Kay; Daniel A Bloch; Tami Crabtree; William C Dement
Journal:  Sleep       Date:  2012-12-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.